Rheinische Friedrich-Wilhelms-Universitaet Bonn

The department investigates cardiovascular diseases with a focus on improving outcomes after high‑risk cardiac surgery. One study evaluates whether an intravenous fish‑oil lipid emulsion can reduce the incidence of postoperative arrhythmias such as atrial fibrillation.

• Prevention of atrial fibrillation after cardiac procedures
• Optimization of peri‑operative lipid therapy
• Critical care strategies for intensive‑care unit patients

Rheinische Friedrich‑Wilhelms‑Universität Bonn leverages over 100 investigators to advance cardiac recovery research in collaboration with commercial partners.

In the field of neoplasms, the site conducts trials aimed at enhancing treatment effectiveness for rare and resistant cancers. Research includes a comparison of carboplatin versus cisplatin in patients with malignant extracranial germ‑cell tumours and a study of pembrolizumab combined with chemotherapy for platinum‑resistant ovarian carcinoma.

• Comparative efficacy of platinum‑based chemotherapy
• Integration of immunotherapy in recurrent ovarian cancer
• Biomarker‑driven approaches for germ‑cell tumor management

As an educational institution with commercial collaboration, the Bonn pediatric hematology/oncology department engages more than a hundred investigators to drive innovative cancer therapies.